Your browser doesn't support javascript.
loading
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
Ansell, Stephen M; Minnema, Monique C; Johnson, Peter; Timmerman, John M; Armand, Philippe; Shipp, Margaret A; Rodig, Scott J; Ligon, Azra H; Roemer, Margaretha G M; Reddy, Nishitha; Cohen, Jonathon B; Assouline, Sarit; Poon, Michelle; Sharma, Manish; Kato, Kazunobu; Samakoglu, Selda; Sumbul, Anne; Grigg, Andrew.
Afiliação
  • Ansell SM; 1 Mayo Clinic, Rochester, MN.
  • Minnema MC; 2 University Medical Center Utrecht Cancer Center, Utrecht, The Netherlands, on behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC.
  • Johnson P; 3 University of Southampton, Southampton, United Kingdom.
  • Timmerman JM; 4 University of California, Los Angeles, Los Angeles, CA.
  • Armand P; 5 Dana-Farber Cancer Institute, Boston, MA.
  • Shipp MA; 5 Dana-Farber Cancer Institute, Boston, MA.
  • Rodig SJ; 5 Dana-Farber Cancer Institute, Boston, MA.
  • Ligon AH; 6 Brigham and Women's Hospital, Boston, MA.
  • Roemer MGM; 6 Brigham and Women's Hospital, Boston, MA.
  • Reddy N; 5 Dana-Farber Cancer Institute, Boston, MA.
  • Cohen JB; 7 Vanderbilt University, Nashville, TN.
  • Assouline S; 8 Emory University, Atlanta, GA.
  • Poon M; 9 Jewish General Hospital, Montreal, Quebec, Canada.
  • Sharma M; 10 National University Cancer Institute, Singapore, Singapore.
  • Kato K; 11 Bristol-Myers Squibb, Princeton, NJ.
  • Samakoglu S; 11 Bristol-Myers Squibb, Princeton, NJ.
  • Sumbul A; 11 Bristol-Myers Squibb, Princeton, NJ.
  • Grigg A; 11 Bristol-Myers Squibb, Princeton, NJ.
J Clin Oncol ; 37(6): 481-489, 2019 02 20.
Article em En | MEDLINE | ID: mdl-30620669

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article